The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of patients with relapsed and refractory chronic lymphocytic leukemia (CLL) who discontinue idelalisib treatment.
 
Jennifer R. Brown
Consulting or Advisory Role - Boehringer Ingelheim; Celgene; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics; ProNAi; Roche/Genentech; Sun Pharma
 
Paolo Ghia
Consulting or Advisory Role - Abbvie; Celgene; Gilead Sciences; Roche
Speakers' Bureau - Gilead Sciences
Research Funding - Gilead Sciences; GlaxoSmithKline; Roche
 
Jeffrey Alan Jones
Consulting or Advisory Role - Genentech/Abbvie; Gilead Sciences; Pharmacyclics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Genentech/Abbvie (Inst); Gilead Sciences (Inst); Janssen (Inst); MedImmune (Inst); Pharmacyclics (Inst)
 
Andrew Pettitt
Honoraria - Bayer Schering Pharma; Genzyme; GlaxoSmithKline; Janssen; Roche
Consulting or Advisory Role - Bayer Schering Pharma; Genzyme; GlaxoSmithKline; Janssen; Novartis; Roche
 
Jeff Porter Sharman
Leadership - US Oncology
Consulting or Advisory Role - Celgene; Genentech; Gilead Sciences; Pharmacyclics; TG Therapeutics
Speakers' Bureau - Gilead Sciences
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics (Inst)
Expert Testimony - Gilead Sciences
 
Loic Ysebaert
Research Funding - Celgene
 
Stephan Stilgenbauer
Honoraria - Abbvie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche; Sanofi
Research Funding - Abbvie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche; Sanofi
Travel, Accommodations, Expenses - Abbvie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche; Sanofi
 
Yeonhee Kim
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Terry Newcomb
Employment - Gilead Sciences
 
Nai-Shun Yao
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences; GlaxoSmithKline
 
Richard R. Furman
Honoraria - Genentech/Roche; Gilead Sciences; Janssen; Pharmacyclics
Consulting or Advisory Role - Genentech/Roche; Gilead Sciences; Janssen Biotech; Pharmacyclics
Speakers' Bureau - Genentech; Janssen; Pharmacyclics
Research Funding - Acerta Pharma
Travel, Accommodations, Expenses - Genentech/Roche; Gilead Sciences; Janssen; Pharmacyclics